Dallas, Texas (PRWEB) August 10, 2012
Within the ever growing medical device industry, it is becoming critical for all stakeholders (manufacturers, buyers, suppliers, marketers, investors, entrepreneurs, governments, watch-dogs, etc) to be on top of the game when it comes to growth opportunities. Covering the United States market for Patient Monitoring Equipment to Gastro Intestinal Devices, Spinal Implants and VCF to Orthopedic Soft Tissue Repair & Sports Medicine, Urological Devices and Orthopedic Biomaterials, ReportsnReports, in partnership with iData Research Inc, offers new market research reports on the U.S. medical devices industry.
The U.S. patient monitoring device and equipment market is expected to exceed $4 billion by 2018. The market for patient monitoring devices and equipment includes multi-parameter vital sign monitors; wireless ambulatory telemetry monitoring; telehealth; intra-cranial pressure monitors and consumables; electromyogram devices and consumables; electroencephalogram monitors; cerebral oximetry monitors and consumables; fetal and neonatal monitors; pulse oximetry monitors, consumables and circuit boards; cardiac output devices and consumables; and blood pressure monitors. Steady growth is expected as monitoring expands to previously unmonitored hospital departments, and is increasingly adopted as a consumer healthcare product.
In 2011, the U.S. market for gastrointestinal endoscopic devices was valued at nearly $1.7 billion. The GI endoscopic market includes: GI endoscopes, capsule endoscopy, virtual colonoscopy, stenting and dilation devices, ERCP devices, biopsy forceps, polypectomy snares, FNA devices, specimen and foreign body removal devices, hemostasis devices, anti-reflux devices, and enteral feeding devices.
The U.S. MIS spinal implant market is expected to exceed $2.6 billion by 2018. Growth in the MIS interbody fusion and MIS pedicle screw markets will continue to cannibalize traditional spinal fusion procedures. Within the U.S. Spinal Implant Market, companies such as DePuy, Medtronic, NuVasive, Synthes and Zimmer lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
The U.S. spinal implant market is expected to approach $7 billion by 2018. Growth in the motion preservation devices segment will continue to be the largest contributor to the rising spinal implant market. Despite many current challenges, positive growth is expected in many segments of the market, as the patient demographics in the U.S. maintain a steady demand for such procedures. One segment will be an exception however, as newer minimally invasive innovations gradually cannibalize that particular market. The motion preservation segment will be the fastest growing segment in the market, and it will continually be driven by novel and emerging technologies.
The U.S. bracing and supports market is expected to exceed $2.48 billion by 2018. The spinal orthosis segment is particularly fast-growing due to the strong correlation between an aging population and the incidence of lower back problems that may require spinal orthoses to prevent further injury or control stability post-surgery. Within the U.S. orthopedic bracing market, companies such as Bledsoe, Breg, DeRoyal, DJO, and Össur lead the market, among many others.
In the orthopedic soft tissue repair and sports medicine market, the hip arthroscopy market experienced the highest growth in 2011, as more surgeons are learning to perform these procedures. All market segments were affected by the economic downturn in 2008 and procedure numbers waned in 2010 and 2011. As the economy began recovering, residual demand boosted procedure volumes. Within the soft tissue and sports medicine market, companies such as Arthrex, ArthroCare, ConMed Linvatec, DePuy Mitek and Smith & Nephew lead the market, among many others.
In 2011, the U.S. market for urological devices was valued at $3.5 billion. In 2011, the prostate cancer treatment device market was both the largest and fastest-growing segment in the total U.S. market for urological devices. Procedural growth in the market is expected to increase over the 2011–2018 forecast period due to the expected rise in the aging population of the baby boomer generation as well as increases in early diagnosis. Within the urological device market, companies such as Coloplast, C.R. Bard, Intuitive Surgical, and Varian Medical Systems lead the market, among many others.
The 2011 figures in the orthopedic biomaterials market show great promise for future performance of the orthopedic biomaterials market. To date there has been a multitude of products introduced to the market, with some becoming spectacular successes. Future growth for this market will be a result of continued improvements in product technology to meet the needs of patients as well as changes in healthcare reform and reimbursement.